Zevra Therapeutics, Inc. (ZVRA)
9.10
+0.13
(+1.45%)
USD |
NASDAQ |
Feb 25, 10:56
Zevra Therapeutics Price : 9.10 for Feb. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Verastem, Inc. | 5.90 |
| ADMA Biologics, Inc. | 15.65 |
| ACADIA Pharmaceuticals, Inc. | 24.81 |
| Alnylam Pharmaceuticals, Inc. | 326.33 |
| Savara, Inc. | 5.78 |
Price Related Metrics
| PE Ratio | 14.43 |
| PS Ratio | 5.890 |
| Price to Book Value | 3.847 |
| Earnings Yield | 6.93% |
| Market Cap | 512.31M |
| Normalized PE Ratio | 6.364 |